Sameek Roychowdhury

Sameek Roychowdhury, MD, PhD

Physician

Overall Patient Satisfaction Rating

stars
4.7 out of 5
56
Reviews
1
Comments

Gender

Male

Biography


As a medical oncologist I specialize in treating patients with advanced prostate and colorectal cancers, including soft tissue sarcoma. Additionally, I serve as an assistant professor of internal medicine, an assistant professor in the department of pharmacology and a member of the Experimental Therapeutics Program at the OSUCCC – James.

I am a research specialist in genomics and tumor DNA sequencing, working on identifying specific cancer therapies that target molecules involved in the progression of cancer. Our multi-disciplinary team evaluates and cares for patients through clinical trials, matches patients to new smart drugs and studies how the drugs impact the cancer.

Proud to be a Buckeye, I earned my undergraduate degree in molecular genetics at Ohio State, and also received my medical degree and a doctorate in immunology here. Since 2012, I have been developing clinical trials focused on genomic alterations.

I’m very proud of the work we do here at OSUCCC – James. It’s an extremely collaborative environment that allows us to develop innovative clinical trials based on the research we do, with the ultimate goal of helping patients enjoy a longer life.

Education and Background

Education

Ohio State University College of Medicine

Columbus, OH

Residencies

University of Michigan Medical Center

Ann Arbor, MI

Fellowship

Medical Oncology

University of Michigan Medical Center

Ann Arbor, MI

Board Certifications

American Board of Internal Medicine

American Board of Internal Medicine (Subspecialty: Medicine Oncology)

Academic Department

Department of Internal Medicine

Division of Medical Oncology


Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 12/20/2018, Dr. Roychowdhury has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.

AbbVie Inc.

IDT DNA Technologies

Incyte Pharmaceuticals

Reviews

Patient Satisfaction Review

The overall patient satisfaction rating is an average of all patient responses to the five questions gathered from the Outpatient Oncology survey, developed by Press Ganey Associates for use in oncology clinics across the country. On behalf of The James, Press Ganey administers the survey to patients who see our providers in an outpatient clinic office. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page

The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of The James.

Overall Ratings (out of 56 reviews)
stars
4.7 out of 5
Kept you informed about your condition and treatment

4.7/ 5

Amount of time spent with you

4.7/ 5

Concern for your questions and issues

4.7/ 5

Skill and knowledge

4.8/ 5

Overall quality of care

4.8/ 5

Patient Comments (1 total comments)

stars
Reviewed: 3/25/2019

Dr. Roychowdhury is the greatest.

Publications

Implementing precision cancer medicine in the genomic era.

Chen HZ, Bonneville R, Roychowdhury S

Semin Cancer Biol 55

4/1/2019

Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers.

Genutis LK, Tomsic J, Bundschuh RA, Brock PL, Williams MD, Roychowdhury S, Reeser JW, Frankel WL, Alsomali M, Routbort MJ, Broaddus RR, Wakely PE Jr, Phay JE, Walker CJ, de la Chapelle A

Thyroid in press

3/27/2019

Clinical Trials | Lead

OSU-18351

OSU-15241

OSU-14078

Related Videos

Newly Discovered Marker Means More Patients Benefiting from Immunotherapy
Pelotonia Funds Breakthrough Cancer Detection Research
What is Cancer?
Back to Find a Doctor Search

Make an Appointment

800-293-5066

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Please enter a keyword (i.e. Name, Location) or choose a Cancer Type

OR